Vistim Labs Closes First Round of Funding
May 11, 2023
Altitude Lab recently announced that Vistim Labs, one of their current first year companies, has successfully closed its seed round, oversubscribed at $800,000. According to Altitude’s report, completing this round will finance Vistim’s go-to-market this year and allow them to raise another $2M this fall to scale their sales in 2024.
Recent News
- Collaboration with Quest Diagnostics to expand kidneyintelX.dkd TM testing in the United States
- Utah Business Innovation Awards Summit Recap
- Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
- Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
